Pulike Biological Engineering Inc
SSE:603566
Pulike Biological Engineering Inc
Retained Earnings
Pulike Biological Engineering Inc
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pulike Biological Engineering Inc
SSE:603566
|
Retained Earnings
¥1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Retained Earnings
¥28.7B
|
CAGR 3-Years
60%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Retained Earnings
¥12.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
25%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Retained Earnings
¥37.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Retained Earnings
¥1.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Retained Earnings
-¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pulike Biological Engineering Inc
Glance View
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
See Also
What is Pulike Biological Engineering Inc's Retained Earnings?
Retained Earnings
1.1B
CNY
Based on the financial report for Sep 30, 2024, Pulike Biological Engineering Inc's Retained Earnings amounts to 1.1B CNY.
What is Pulike Biological Engineering Inc's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
5%
Over the last year, the Retained Earnings growth was -6%.
You don't have any saved screeners yet